Journal article · 2026 · Open access
NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW
World Journal of Pharmaceutical Research · Published 1 February 2026 · DOI 10.5281/zenodo.18426659
In brief
“NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW” is a 2026 journal article by *1Mr. Ganesh D. Parihar, 2Mr. Harshal S. Nage, 3Mr. Mukesh S. Naiknawre, 4Ms. Anuradha. K. Kendhale, 5Ms. Sakshi S. Ghuge, 6Mr. Devanand H. Dongre, 7Dr. Prafulla R. Tathe, published in World Journal of Pharmaceutical Research. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at World Journal of Pharmaceutical Research.
- Citations
- 0
- Authors
- 1
Abstract
The majority of new drug molecules discovered through high-throughput screening possess poor aqueous solubility, resulting in low oral bioavailability and limited clinical success. Nearly 40–70% of small-molecule drugs fall into Biopharmaceutics Classification System (BCS) Class II or IV, where solubility and dissolution are the rate-limiting steps in absorption. Nanocrystal technology has emerged as a simple yet powerful strategy to address these issues by reducing drug particles to the nanometer scale, thereby increasing surface area, dissolution velocity, and apparent saturation solubility. Unlike polymeric nanoparticles or lipid carriers, nanocrystals consist almost entirely of the pure active pharmaceutical ingredient stabilized by surfactants or polymers, offering high drug loading and improved performance. This review provides a comprehensive overview of nanocrystals as a drug delivery approach, discussing their theoretical basis, preparation methods, stabilizers, characterization techniques, pharmaceutical applications, marketed products, regulatory aspects, stability concerns, and future perspectives. Tables and figures are included to aid clarity.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Tathe, G. D. P. H. S. N. M. S. N. A. K. K. S. S. G. D. H. D. P. R. (2026). NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW. World Journal of Pharmaceutical Research. https://doi.org/10.5281/zenodo.18426659
MLA 9
Tathe, *1Mr. Ganesh D. Parihar, 2Mr. Harshal S. Nage, 3Mr. Mukesh S. Naiknawre, 4Ms. Anuradha. K. Kendhale, 5Ms. Sakshi S. Ghuge, 6Mr. Devanand H. Dongre, 7Dr. Prafulla R. “NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW.” World Journal of Pharmaceutical Research, 2026. https://doi.org/10.5281/zenodo.18426659.
Chicago
Tathe, *1Mr. Ganesh D. Parihar, 2Mr. Harshal S. Nage, 3Mr. Mukesh S. Naiknawre, 4Ms. Anuradha. K. Kendhale, 5Ms. Sakshi S. Ghuge, 6Mr. Devanand H. Dongre, 7Dr. Prafulla R. 2026. “NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW.” World Journal of Pharmaceutical Research. https://doi.org/10.5281/zenodo.18426659.
Harvard
Tathe, G. D. P. H. S. N. M. S. N. A. K. K. S. S. G. D. H. D. P. R. (2026) ‘NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW’, World Journal of Pharmaceutical Research. doi:10.5281/zenodo.18426659.
IEEE
G. D. P. H. S. N. M. S. N. A. K. K. S. S. G. D. H. D. P. R. Tathe, “NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW,” World Journal of Pharmaceutical Research, 2026, doi: 10.5281/zenodo.18426659.
BibTeX
@article{tathe2026nanocrystals,
title = {{NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW}},
author = {Tathe, *1Mr. Ganesh D. Parihar, 2Mr. Harshal S. Nage, 3Mr. Mukesh S. Naiknawre, 4Ms. Anuradha. K. Kendhale, 5Ms. Sakshi S. Ghuge, 6Mr. Devanand H. Dongre, 7Dr. Prafulla R.},
journal = {World Journal of Pharmaceutical Research},
year = {2026},
doi = {10.5281/zenodo.18426659},
url = {https://doi.org/10.5281/zenodo.18426659}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- nanocrystals
- bioavailability enhancement
- poorly water-soluble drugs
- dissolution rate
- oral bioavailability
- BCS Class II and IV drugs
- stabilizers
- surfactants
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Tathe, G. D. P. H. S. N. M. S. N. A. K. K. S. S. G. D. H. D. P. R. (2026). NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW. World Journal of Pharmaceutical Research. https://doi.org/10.5281/zenodo.18426659
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at World Journal of Pharmaceutical Research.
Who wrote this paper?
*1Mr. Ganesh D. Parihar, 2Mr. Harshal S. Nage, 3Mr. Mukesh S. Naiknawre, 4Ms. Anuradha. K. Kendhale, 5Ms. Sakshi S. Ghuge, 6Mr. Devanand H. Dongre, 7Dr. Prafulla R. Tathe.
What is the DOI of this paper?
10.5281/zenodo.18426659. The permanent link is https://doi.org/10.5281/zenodo.18426659.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.